AP
Therapeutic Areas
Intrance Medical Systems Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lecigon® (U.S. name not specified) | Advanced Parkinson's Disease | Phase 3 |
Leadership Team at Intrance Medical Systems
LB
Lars Birgerson, M.D., Ph.D.
Chief Executive Officer and Board Member
UR
Ulf Rosén
Co-Founder
RB
Roger Bolsöy
Co-Founder